Racho, Krizzia Zahirah A.

HRN: 26-87-40  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
03/28/2025
04/04/2025
PO
0.8 Ml
Q 12
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: